Kramer K - Search Results

1

A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.

Becher OJ, Gilheeney SW, Khakoo Y, Lyden DC, Haque S, De Braganca KC, Kolesar JM, Huse JT, Modak S, Wexler LH, Kramer K, Spasojevic I, Dunkel IJ. Becher OJ, et al. Among authors: kramer k. Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26409. Epub 2016 Dec 30. Pediatr Blood Cancer. 2017. PMID: 28035748 Clinical Trial.

2

High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.

Kushner BH, Heller G, Cheung NK, Wollner N, Kramer K, Bajorin D, Polyak T, Meyers PA. Kushner BH, et al. Among authors: kramer k. J Clin Oncol. 1998 Sep;16(9):3016-20. doi: 10.1200/JCO.1998.16.9.3016. J Clin Oncol. 1998. PMID: 9738570 Clinical Trial.

3

Clinically critical impact of molecular genetic studies in pediatric solid tumors.

Kushner BH, LaQuaglia MP, Cheung NK, Kramer K, Hamelin AC, Gerald WL, Ladanyi M. Kushner BH, et al. Among authors: kramer k. Med Pediatr Oncol. 1999 Dec;33(6):530-5. doi: 10.1002/(sici)1096-911x(199912)33:6<530::aid-mpo2>3.0.co;2-j. Med Pediatr Oncol. 1999. PMID: 10573575

4

Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.

Kushner BH, Heller G, Kramer K, Cheung NK. Kushner BH, et al. Among authors: kramer k. Cancer. 2000 Nov 15;89(10):2122-30. Cancer. 2000. PMID: 11066054 Clinical Trial.

5

Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.

Kushner BH, Kramer K, Meyers PA, Wollner N, Cheung NK. Kushner BH, et al. Among authors: kramer k. Med Pediatr Oncol. 2000 Nov;35(5):468-74. doi: 10.1002/1096-911x(20001101)35:5<468::aid-mpo5>3.0.co;2-p. Med Pediatr Oncol. 2000. PMID: 11070479 Clinical Trial.

6

Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.

Kramer K, Cheung NK, Humm JL, Dantis E, Finn R, Yeh SJ, Antunes NL, Dunkel IJ, Souwedaine M, Larson SM. Kramer K, et al. Med Pediatr Oncol. 2000 Dec;35(6):716-8. doi: 10.1002/1096-911x(20001201)35:6<716::aid-mpo51>3.0.co;2-0. Med Pediatr Oncol. 2000. PMID: 11107154 Clinical Trial.

7

Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.

Modak S, Kramer K, Gultekin SH, Guo HF, Cheung NK. Modak S, et al. Among authors: kramer k. Cancer Res. 2001 May 15;61(10):4048-54. Cancer Res. 2001. PMID: 11358824

8

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.

Cheung NK, Kushner BH, LaQuaglia M, Kramer K, Gollamudi S, Heller G, Gerald W, Yeh S, Finn R, Larson SM, Wuest D, Byrnes M, Dantis E, Mora J, Cheung IY, Rosenfield N, Abramson S, O'Reilly RJ. Cheung NK, et al. Among authors: kramer k. Med Pediatr Oncol. 2001 Jan;36(1):227-30. doi: 10.1002/1096-911X(20010101)36:1<227::AID-MPO1055>3.0.CO;2-U. Med Pediatr Oncol. 2001. PMID: 11464891 Clinical Trial.

9

Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.

Kushner BH, Cheung NK, Kramer K, Dunkel IJ, Calleja E, Boulad F. Kushner BH, et al. Among authors: kramer k. Bone Marrow Transplant. 2001 Sep;28(6):551-6. doi: 10.1038/sj.bmt.1703213. Bone Marrow Transplant. 2001. PMID: 11607767 Clinical Trial.

10

Chronic neuroblastoma.

Kushner BH, Kramer K, Cheung NK. Kushner BH, et al. Among authors: kramer k. Cancer. 2002 Sep 15;95(6):1366-75. doi: 10.1002/cncr.10800. Cancer. 2002. PMID: 12216106 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,423 results

Search Page